Microsatellite instability: a review of what the oncologist should know
暂无分享,去创建一个
Hui Luo | Lianfang Huang | Kai Li | Xiao Zhu | Haiqing Luo
[1] M. Wing,et al. Detection of Microsatellite Instability Biomarkers via Next-Generation Sequencing. , 2019, Methods in molecular biology.
[2] Dongpei Li,et al. The cancer exosomes: Clinical implications, applications and challenges , 2020, International journal of cancer.
[3] G. Sauter,et al. High homogeneity of mismatch repair deficiency in advanced prostate cancer , 2019, Virchows Archiv.
[4] Xiao Zhu,et al. Transcriptome analysis reveals an important candidate gene involved in both nodal metastasis and prognosis in lung adenocarcinoma , 2019, Cell & Bioscience.
[5] I. Nagtegaal,et al. Microsatellite instability screening in colorectal adenomas to detect Lynch syndrome patients? A systematic review and meta-analysis , 2019, European Journal of Human Genetics.
[6] Jiaqi Tang,et al. Transcriptional regulation in model organisms: recent progress and clinical implications , 2019, Open Biology.
[7] Dongpei Li,et al. Circular RNAs: The star molecules in cancer. , 2019, Molecular aspects of medicine.
[8] R. Kurzrock,et al. Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patients , 2019, International journal of cancer.
[9] Jeffrey E. Lee,et al. Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma , 2019, Journal of Immunotherapy for Cancer.
[10] Yoon Young Choi,et al. Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Jin-liang Wang,et al. Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer , 2019, Cancer Immunology, Immunotherapy.
[12] L. Looi,et al. Screening for microsatellite instability in colorectal carcinoma: Practical utility of immunohistochemistry and PCR with fragment analysis in a diagnostic histopathology setting. , 2019, The Malaysian journal of pathology.
[13] Yongmei Huang,et al. The single-cell sequencing: new developments and medical applications , 2019, Cell & Bioscience.
[14] Tae Won Kim,et al. Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial. , 2019, The Lancet. Oncology.
[15] J. Taube,et al. Intratumoral Adaptive Immunosuppression and Type 17 Immunity in Mismatch Repair Proficient Colorectal Tumors , 2019, Clinical Cancer Research.
[16] James M. McFarland,et al. WRN Helicase is a Synthetic Lethal Target in Microsatellite Unstable Cancers , 2019, Nature.
[17] David M. Thomas,et al. Genomic stratification and liquid biopsy in a rare adrenocortical carcinoma (ACC) case, with dual lung metastases , 2019, Cold Spring Harbor molecular case studies.
[18] W. Frankel,et al. Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers. , 2019, Thyroid : official journal of the American Thyroid Association.
[19] A. Badr,et al. Microsatellite instability profiling in Egyptian bladder cancer patients: A pilot study. , 2019, Current problems in cancer.
[20] Donna Niedzwiecki,et al. Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Ahmet Zehir,et al. Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] Yoon Young Choi,et al. MSI-GC-01: Individual patient data (IPD) meta-analysis of microsatellite instability (MSI) and gastric cancer (GC) from four randomized clinical trials (RCTs). , 2019, Journal of Clinical Oncology.
[23] Yoon Young Choi,et al. Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study. , 2019, Annals of surgery.
[24] P. Kantoff,et al. Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade , 2019, JAMA oncology.
[25] A. Duval,et al. Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status , 2019, JAMA oncology.
[26] A. Kirichenko,et al. Microsatellite Instability (MSI) as an Independent Predictor of Pathologic Complete Response (PCR) in Locally Advanced Rectal Cancer: A National Cancer Database (NCDB) Analysis. , 2020, Annals of surgery.
[27] E. Oki,et al. Recent Incidence Trend of Surgically Resected Esophagogastric Junction Adenocarcinoma and Microsatellite Instability Status in Japanese Patients , 2018, Digestion.
[28] M. Kloor,et al. Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma , 2018, British Journal of Cancer.
[29] D. Le,et al. Integrating Immunotherapy Into Colorectal Cancer Care. , 2018, Oncology.
[30] B. Thapa,et al. Mismatch Repair Protein Defects and Microsatellite Instability in Malignant Pleural Mesothelioma , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[31] H. Samadi kafil,et al. Evaluation of microsatellite instability in tumor and tumor marginal samples of sporadic colorectal cancer using mononucleotide markers , 2018, EXCLI journal.
[32] Takayuki Takahashi,et al. Synchronous endometrial and ovarian cancer in Lynch syndrome with a MSH2 germline mutation: A case report , 2018, Molecular and clinical oncology.
[33] K. Hata,et al. Predictors for High Microsatellite Instability in Patients with Colorectal Cancer Fulfilling the Revised Bethesda Guidelines , 2018, AntiCancer Research.
[34] Joon-Oh Park,et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer , 2018, Nature Medicine.
[35] R. Reis,et al. Advantage of HSP110 (T17) marker inclusion for microsatellite instability (MSI) detection in colorectal cancer patients , 2018, Oncotarget.
[36] V. Brabec,et al. Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells , 2018, Oncotarget.
[37] Ronald J. Hause,et al. Accurate Pan-Cancer Molecular Diagnosis of Microsatellite Instability by Single-Molecule Molecular Inversion Probe Capture and High-Throughput Sequencing. , 2018, Clinical chemistry.
[38] P. Nelson,et al. Microsatellite instability in prostate cancer by PCR or next-generation sequencing , 2018, Journal of Immunotherapy for Cancer.
[39] Zachary S. Lorsch,et al. Correction: Corrigendum: Sex-specific transcriptional signatures in human depression , 2018, Nature Medicine.
[40] M. Kloor,et al. Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analyses , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[41] A. Clark,et al. Satellite DNA evolution: old ideas, new approaches. , 2018, Current opinion in genetics & development.
[42] M. Sawyer,et al. Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] V. G. Biju,et al. Assessment of microsatellite instability for screening bladder cancer in high-risk population , 2018, Journal of cancer research and therapeutics.
[44] R. Soslow,et al. Molecular insights into the classification of high-grade endometrial carcinoma. , 2017, Pathology.
[45] First Comprehensive Companion Diagnostic OK'd. , 2018, Cancer discovery.
[46] D. Tritchler,et al. An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer. , 2018, Gynecologic oncology.
[47] Nivolumab plus Ipilimumab Achieves Responses in dMMR/MSI-H Tumors. , 2018, Cancer discovery.
[48] Yingyan Yu. Molecular classification and precision therapy of cancer: immune checkpoint inhibitors , 2018, Frontiers of Medicine.
[49] A. Santoro,et al. Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma , 2017, PloS one.
[50] K. Cole,et al. Comprehensive Analysis of Hypermutation in Human Cancer , 2017, Cell.
[51] Russell Bonneville,et al. Landscape of Microsatellite Instability Across 39 Cancer Types. , 2017, JCO precision oncology.
[52] J. Shendure,et al. Corrigendum: Classification and characterization of microsatellite instability across 18 cancer types , 2017, Nature Medicine.
[53] J. Desai,et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. , 2017, The Lancet. Oncology.
[54] M. Garrido-Ramos. Satellite DNA: An Evolving Topic , 2017, Genes.
[55] Ahmet Zehir,et al. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing , 2017, BMC Medical Genomics.
[56] Levi Garraway,et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden , 2017, Genome Medicine.
[57] S. Paik,et al. Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype , 2017, Oncotarget.
[58] T. Patel,et al. Microsatellite Instability in Chronic Myeloid Leukemia using D17S261 and D3S643 markers: A Pilot Study in Gujarat Population. , 2017, Indian journal of cancer.
[59] C. Bloomfield,et al. No evidence for microsatellite instability in acute myeloid leukemia , 2017, Leukemia.
[60] Ahmed Kamel,et al. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.
[61] M. Rugge,et al. Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial , 2017, JAMA oncology.
[62] H. Sakamoto,et al. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases. , 2017, Oncology reports.
[63] Lauren L. Ritterhouse,et al. Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression , 2017, Oncoimmunology.
[64] Russell Bonneville,et al. Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS , 2016, Oncotarget.
[65] J. Kench,et al. Hypermutation In Pancreatic Cancer. , 2017, Gastroenterology.
[66] Ö. Türeci,et al. Corrigendum: Positively selected enhancer elements endow osteosarcoma cells with metastatic competence , 2017, Nature Medicine.
[67] P. Park,et al. A molecular portrait of microsatellite instability across multiple cancers , 2016, Nature Communications.
[68] L. Diaz,et al. Preliminary results of a phase II study: PD-1 blockade in mismatch repair–deficient, recurrent or persistent endometrial cancer , 2016 .
[69] Markovic Srdjan,et al. Microsatellite instability & survival in patients with stage II/III colorectal carcinoma , 2016, The Indian journal of medical research.
[70] Yoon Young Choi,et al. Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives , 2015, Journal of pathology and translational medicine.
[71] F. Roviello,et al. Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer , 2016, Annals of Surgical Oncology.
[72] Lauren L. Ritterhouse,et al. Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1. , 2015, JAMA oncology.
[73] R. Monasson,et al. Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells , 2015, Proceedings of the National Academy of Sciences.
[74] Hoguen Kim,et al. Usefulness of Immunohistochemistry for Microsatellite Instability Screening in Gastric Cancer , 2015, Gut and liver.
[75] Bert Vogelstein,et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.
[76] B. Vogelstein,et al. PD-1 blockade in tumors with mismatch repair deficiency. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[77] K. Koike,et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.
[78] A. Hartmann,et al. Low frequency of HNPCC-associated microsatellite instability and aberrant MMR protein expression in early-onset bladder cancer. , 2014, American journal of clinical pathology.
[79] P. Gibbs,et al. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[80] A. Evans,et al. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. , 2013, European urology.
[81] M. Bronner,et al. A Five-marker Panel in a Multiplex PCR Accurately Detects Microsatellite Instability-high Colorectal Tumors Without Control DNA , 2012, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[82] G. Tallini,et al. T[20] repeat in the 3′-untranslated region of the MT1X gene: a marker with high sensitivity and specificity to detect microsatellite instability in colorectal cancer , 2012, International Journal of Colorectal Disease.
[83] Fred H. Gage,et al. BRCA1 tumor suppression occurs via heterochromatin mediated silencing , 2011, Nature.
[84] R. Jover,et al. EPCAM germ line deletions as causes of Lynch syndrome in Spanish patients. , 2010, The Journal of molecular diagnostics : JMD.
[85] R. Labianca,et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[86] M. Linnebacher,et al. Identification of an MSI-H Tumor-Specific Cytotoxic T Cell Epitope Generated by the (−1) Frame of U79260(FTO) , 2010, Journal of biomedicine & biotechnology.
[87] P. Lara,et al. Microsatellite instability predicts clinical outcome in radiation-treated endometrioid endometrial cancer. , 2010, International journal of radiation oncology, biology, physics.
[88] P. Hutter,et al. Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation , 2010, Familial Cancer.
[89] Minshan Chen,et al. Single nucleotide polymorphism of rs430397 in the fifth intron of GRP78 gene and clinical relevance of primary hepatocellular carcinoma in Han Chinese: Risk and prognosis , 2009, International journal of cancer.
[90] Zhenzhu Zheng,et al. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions]. , 2007, Zhonghua zhong liu za zhi [Chinese journal of oncology].
[91] B. Robinson,et al. 5-Fluorouracil (5FU) treatment does not influence invasion and metastasis in microsatellite unstable (MSI-H) colorectal cancer , 2006, International Journal of Colorectal Disease.
[92] Lawrence J. Burgart,et al. Development of a Fluorescent Multiplex Assay for Detection of MSI-High Tumors , 2004, Disease markers.
[93] Fengzhu Sun,et al. The relationship between microsatellite slippage mutation rate and the number of repeat units. , 2003, Molecular biology and evolution.
[94] A. Duval,et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. , 2002, Gastroenterology.
[95] E. Ozer,et al. Microsatellite instability in early-onset breast cancer. , 2002, Pathology, research and practice.
[96] J. Nesland,et al. Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[97] H. Yamamoto,et al. Adenocarcinomas with Widespread Microsatellite Instability Genetic and Clinical Features of Human Pancreatic Ductal Updated , 2001 .
[98] M. Choti,et al. NCCN Practice Guidelines for Colorectal Cancer. , 2000, Oncology.
[99] M. Choti,et al. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. , 2000, The American journal of pathology.
[100] J. Eshleman,et al. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. , 2000, The Journal of molecular diagnostics : JMD.
[101] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[102] J. Rüschoff,et al. Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[103] D. Schaid,et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. , 1998, Cancer research.
[104] D. Queller,et al. Detection of highly polymorphic microsatellite loci in a species with little allozyme polymorphism , 1993, Molecular ecology.